ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DORINA OMARI M.D.

100 CUMMINGS CTR SUITE 166 D

Beverly | Massachusetts | 01915

(978) 712-3360

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,734Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 2456

$8,536 Total Retail Price of All Prescriptions

Rank: 2441 out of 2456

232 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

27% of this provider’s 232 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 232 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 10,862 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$1 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
FUROSEMIDE 612 562 1 8
SIMVASTATIN 512 461 2 2
LISINOPRIL 486 435 3 1
CITALOPRAM HBR 391 359 4 14
OMEPRAZOLE 385 343 5 3
MIRTAZAPINE 369 369 6 29
LEVOTHYROXINE SODIUM 361 324 7 4
TRAZODONE HCL 301 286 8 17
GABAPENTIN 290 273 9 16
NAMENDA 283 283 10 42
METOPROLOL SUCCINATE 251 224 11 13
WARFARIN SODIUM 211 207 12 9
METOPROLOL TARTRATE 208 205 13 10
AMLODIPINE BESYLATE 205 205 14 5
QUETIAPINE FUMARATE 203 193 15 47
DONEPEZIL HCL 201 186 16 23
RISPERIDONE 200 200 17 50
SERTRALINE HCL 155 135 18 21
POTASSIUM CHLORIDE 151 135 19 33
DIVALPROEX SODIUM 146 124 20 51
ATENOLOL 129 116 21 6
LIDODERM 125 121 22 58
TAMSULOSIN HCL 123 123 23 32
LOSARTAN POTASSIUM 123 123 23 18
ADVAIR DISKUS 122 93 25 36
ALENDRONATE SODIUM 119 105 26 19
OLANZAPINE 112 108 27 57
ISOSORBIDE MONONITRATE ER 105 91 28 48
ATORVASTATIN CALCIUM 105 80 28 12
DIGOXIN 105 104 28 49
PREDNISONE 104 101 31 39
NYSTOP 96 89 32 125
FINASTERIDE 87 87 33 66
AMIODARONE HCL 86 86 34 203
FAMOTIDINE 86 76 34 84
IPRATROPIUM-ALBUTEROL 85 83 36 85
METFORMIN HCL 84 84 37 11
CLOPIDOGREL 79 79 38 55
BUPROPION HCL SR 71 58 39 119
SEROQUEL 70 70 40 102
OXYCONTIN 67 60 S2 41 129
ESCITALOPRAM OXALATE 66 66 42 116
PLAVIX 65 65 43 79
HYDROCODONE-ACETAMINOPHEN 65 61 S3 43 20
CYMBALTA 65 65 43 65
KLOR-CON M20 61 48 46 69
CARVEDILOL 60 53 47 54
NITROFURANTOIN 59 59 48 224
BUSPIRONE HCL 57 52 49 157
HYDROCHLOROTHIAZIDE 56 51 50 7
OXYBUTYNIN CHLORIDE ER 53 45 51 94
CLOZAPINE 53 53 51 75
HYDRALAZINE HCL 53 53 51 105
LATANOPROST 52 52 54 156
RANITIDINE HCL 52 52 54 31
SPIRONOLACTONE 52 37 54 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.